Foley Partner Donald Schroeder was quoted in a Hotel Management article, “Identifying, mitigating joint-employer liability remains crucial for hotels,” discussing the importance of mitigating joint-employer liability for hotels.
Schroeder explained, as it relates to employers and employees determining who is in control within a joint-employment situation: “Now is a good time for both parties in a relationship to review their contracts in view of the [Browning-Ferris] decision as it is currently constituted.”
He also stated that is important for employers and employees to “ensure you are consistent in how you apply the contractual provisions to the extent that you can avoid blurring the line between the two entities.”
Schroeder explained, as it relates to employers and employees determining who is in control within a joint-employment situation: “Now is a good time for both parties in a relationship to review their contracts in view of the [Browning-Ferris] decision as it is currently constituted.”
He also stated that is important for employers and employees to “ensure you are consistent in how you apply the contractual provisions to the extent that you can avoid blurring the line between the two entities.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”